Aqemia, for its part, says it’s using physics and statistical mechanics algorithms to train a generative AI system, which then helps design potential drug candidates for “critical diseases.” The initial focus is on oncology (cancer) & immuno-oncology (using the body’s immune system to fight cancer).
add a skeleton here at some point
over 1 year ago